Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Medtronic (MDT) made a big leap toward the future of healthcare in diabetes treatment innovations when it launched what media have hailed as the first artificial pancreas, the MiniMed 530G, earlier this fall. But it?s actually just an ?artificial pancreas device system.? It?s not a true artificial pancreas. The MiniMed 530G is only Step 1, DexCom CEO Terry Gregg said. It will still be about five years or more before such a device can truly function as an artificial pancreas in an optimal way for Type 1 diabetes patients, he said.
Gregg was the President and COO of MiniMed when Medtronic acquired the medical devices company for $3.4 billion in 2001. He?s been a Juvenile Diabetes Research Foundation Angel Award recipient, and serves on the Scripps Translational Science Institute advisory board. He?s a definite thought leader in diabetes treatment innovation.
So what will it take to move from where we are today to a true artificial pancreas?
http://medcitynews.com/2013/11/medt...e-the-4-more-steps-type-1-diabetes-treatment/
Gregg was the President and COO of MiniMed when Medtronic acquired the medical devices company for $3.4 billion in 2001. He?s been a Juvenile Diabetes Research Foundation Angel Award recipient, and serves on the Scripps Translational Science Institute advisory board. He?s a definite thought leader in diabetes treatment innovation.
So what will it take to move from where we are today to a true artificial pancreas?
http://medcitynews.com/2013/11/medt...e-the-4-more-steps-type-1-diabetes-treatment/